Strand Therapeutics reports early positive data for STX-001, a self-replicating mRNA cancer therapy, showing safety and ...

Strand Therapeutics, a leader in next-generation mRNA-based therapeutics, today announced exciting preliminary Phase 1 ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

And these shortened messages cannot build a complete protein. "Only one cut in your mRNA strand can be enough to lose your function," says Verbeke, the pharmaceutical scientist. To slow ...

The yeast nuclear endonuclease Rnt1 has a well-characterized role in the maturation of many ncRNA precursors. However, the scope and consequence of its function in mRNA degradation pathways is much ...

Normally, multiple ribosomes bind to a single mRNA strand simultaneously. However, in certain situations, when the mRNA is damaged, two ribosomes can collide while translating the mRNA. Conti’s team ...

Company to share updates at the AACR and ASGCT annual meetings Strand Therapeutics Inc., the programmable mRNA company developing curative therapies for cancer and beyond, will present preclinical ...

mRNA is synthesized by the enzyme RNA polymerase. This occurs by using the sequence of bases in a DNA strand to create a complementary mRNA strand. This pre-mRNA is then processed—spliced ...

My biggest concern regarding Moderna is that it's limited. Human immune systems go berserk when they notice a free-floating mRNA strand. This is why all of Moderna's commercial-stage drugs and ...

On the five-year anniversary of the Covid pandemic, a Times reporter, Apoorva Mandavilli, looks back at the success of, and the backlash to, the mRNA vaccine. There’s no question that this ...

That leaves an exon, a coding sequence free to be joined to the rest of the RNA exon coding sequence to produce a mature messenger RNA (mRNA) strand. The mature mRNA then possesses the ...